LabCorp Forms Lab-Alliance With Kentucky-Based Health Firm
Zacks Investment Research | Mar 22, 2018 10:10PM ET
Over the last few days, Laboratory Corporation of Americas Holdings (NYSE:LH) (popularly known as LabCorp) has been dominating headlines on several strategic developments. Following its extended alliance with Interpace Diagnostics (NASDAQ:IDXG) announced earlier this week, LabCorp has formed of one more joint venture — this time with Appalachian Regional Healthcare.
This multi-year, comprehensive laboratory collaboration will help LabCorp provide high-quality, high-value and standardized laboratory diagnostics to Appalachian Regional Healthcare’s hospital-based labs. Apart from technical services, LabCorp will aid in reference testing for Appalachian Regional Healthcare’s entire network of facilities and clinicians plus make enhanced information technology and data analytics accessible to help improve the delivery of patient care.
This alliance is expected to strengthen LabCorp’s diagnostic testing foothold in Eastern Kentucky and Southern West Virginia.
Progress on Strategic Collaborations
We note that LabCorp has fortified its footprint in the diagnostics space through both organic and inorganic means plus plans to collaborate with the leading companies and academic institutions to build a wider portfolio of tests.
The company continues to increase its scale and competencies in clinical laboratory medicine via acquisitions ranging from routine capabilities to highly esoteric testing. Among its recent alliances, under the new agreement with Interpace Diagnostics, Dianon Pathology — a member of the LabCorp Specialty Testing Group — will perform the thyroid biopsy analysis.
This apart, worth mentioning are the company’s two major health systems partnerships, Mount Sinai Health System and PAML, a market-leading reference and outreach laboratory based in Pacific Northwest. Per LabCorp, these anchor health systems will gradually emerge as research hubs, improving access to trials as well as Covance's site activation and investigator, and patient recruitment capabilities.
Other recent collaborations include a strategic partnership with Thermo Fisher (NYSE:TMO) , through which, the Thermo Fisher Oncomine Dx target panel was launched for non-small cell lung cancer patients. Also, riding on its partnership with drug retailer Walgreens (NASDAQ:WBA) , the company works on developing and operating patient service centers within select Walgreens stores. Besides these, significant is its tie-up with Japan-based Sysmex Corporation, a foremost clinical laboratory services provider and Roche, the world's reputed biotech company.
Share Price Performance
Over the past three months, shares of LabCorp have outperformed its Zacks Investment Research
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.